The radioprotective effect of a hydroalcoholic extracted material (REC-2000) from the rhizome of Podophyllum hexandrum was studied in mice exposed to lethal γ γ radiation (10 Gy). The extract (REC-2000) was found to restore the hemoglobin content (14.73 ± ± 0.33) and total leukocyte count (TLC) (4166.66 ± ± 0.02) in lethally (10 Gy) γ γ-irradiated mice on the 15th day in comparison to the radiation control mice. The hemoglobin content of the drug + radiation group was observed to be significantly (21.25%) higher than the radiation control group on the 10th day. Similarly, the TLC was significantly increased (83.33 times) in the drug + radiation group as compared to a radiation (10 Gy) only group on the 10th day. Enhanced expression of heme-oxygenase-1 and Bcl-2 protein observed by Western blotting further supports the observation of hemopoietic recovery in irradiated mice. These findings indicate that the bioactive constituents present in REC-2000 exert the radioprotective effect by modulating the hemopoietic system.
Radiation is a double-edged sword. In the clinic, radiotherapy is an important treatment modality and provides benefit to cancer patients, particularly in cases where surgical interventions are not advisable, for example, lung, head, and neck cancers. On the other hand, high doses of radiation result in severe side effects that often lead to discontinuation of treatment cycles. 1 Any drug that can provide therapeutic differentiation between cancerous and normal tissue, and protect the latter, would be of great utility in the clinic. The development of radioprotectors is important from the point of view of improving the effectiveness of cancer treatment multifold, and also for strategic reasons (planned and unplanned radiation exposures).
Radiation-induced hematological alterations have been extensively studied with 2 main aims: (1) to under-stand the intricate pathways involved in radiation-mediated damage and (2) to design and develop novel radioprotective drugs for modulation of radiation-induced lethal damage, thereby providing better treatment modalities. Several synthetic radioprotective compounds increase patient tolerance to radiotherapy, but their clinical utility is limited because they are expensive and also manifest toxicity upon repeated administration. 2 After whole-body radiation exposure, manifestation of injury is clearly reflected in peripheral blood, 3 the quantitative effects being more significant than the qualitative changes. 4 The damaging effects of radiation on stem cells can cause bone marrow failure and leukemia (eg, acute myeloid leukemia), as was evident in the victims of Hiroshima and Nagasaki, Japan. Radiation-induced chromosomal breaks, recombinations, and activation of oncogenes by point mutations induce leukemogenesis in mammals. Children born to mothers exposed to x-ray during pregnancy are at an increased risk of developing leukemia. 5 Despite extensive screening of synthetic radioprotectors for clinical use during radiotherapy, no single compound has emerged as an efficient radioprotector. Interest has now been generated to develop potential drugs of plant origin for the modification of radiation damage. Screening of natural products represents a major research avenue today for the discovery of new radioprotective/radiorecovery drugs. 6 Studies from our laboratory have shown that medicinal plants, and herbal preparations therefrom, can render efficient radioprotection. [6] [7] Of the several plants that were screened by us, Podophyllum hexandrum Royle (Berberidaceae) rendered significant radioprotection. 6, 8 The plant contains several bioactive constituents, 9 which render potent antitumor, antioxidant, and immunostimulant activity in vivo and specifically mitigate lethal ionizing radiation-induced toxicity. P. hexandrum is a source of podophyllotoxin, the basis of the semisynthetic chemotherapy drugs etoposide, teniposide, and etopophos. Due to extensive exploitation, in view of its anticancer potential, P. hexandrum has been listed in the Red Data Book. Wild populations are currently considered endangered in several regions of the Himalayas (extending from Jammu and Kashmir to Sikkim).
Our previous studies showed the protective effect of aqueous extract of P. hexandrum against ionizing radiation in in vitro/in vivo model systems. 10 However, REC-2000 differs substantially from the aqueous extract in terms of nature and relative percentage of various constituents. The overall radioprotection offered, that is, whole-body survival on 30th day postexposure to 10 Gy lethal gamma radiation by REC-2000, was >92%, as compared to the aqueous extract (88.8%). The present study has, therefore, focused on evaluation of the protective effect of REC-2000 against lethal ionizing radiation (10 Gy), specifically on the hemopoietic system and protein expression.
Materials and Methods

Preparation of Plant Extract
The underground plant material (rhizomes) of P. hexandrum (synonyms: Podophyllum emodi Wallich ex Royle and Sinopodophyllum hexandrum [Royle] Ying), a member of the family Berberidaceae, was obtained from an identified wild population in the high-altitude region of the Himalayas (Leh and Ladakh, J & K, India). The rhizomes were kindly provided by Dr OP Chaurasia, Scientist, Field Research Laboratory (FRL), Leh, and authenticated on the basis of botanicalcharacteristics by Dr OP Chaurasia and Dr Rajesh Arora, Scientist, INMAS, Delhi. A voucher specimen of the plant material is available at FRL, Leh. The air-dried rhizomes were cut into small pieces and crushed in a grinder. Soxhlet extraction was carried out in 50% ethyl alcohol using the powdered material of Podophyllum for 72 to 96 hours. The extract thus obtained was centrifuged (1000 rpm) in a refrigerated centrifuge (Sorvall Instruments, Ramsey, MN) to obtain a clear solution. The solution was concentrated in a rotary evaporator (Buchi Labortechnik AG, Flawil, Switzerland) at a temperature below 60°C. The yield of the extract on weight by volume basis was 1.84%. The extract was code-named REC-2000 and was freshly dissolved in sterile triple distilled water immediately before use.
High-Performance Liquid Chromatography
High-performance liquid chromatograph (HPLC) analysis was carried out on a C 18 reverse-phase column (size 250 × 4.6, Hypersil) using a Thermo Finnagan HPLC apparatus. A mixture of methanol and 0.3% phosphoric acid (1:1) was used as the mobile phase with a flow rate of 0.6 mL/min, and the different phytoconstituents present in the extract were detected at 290 nm wavelength using a UV-visible detector.
Animals
Animal care and handling was carried out according to the guidelines of the National Institutes of Health, United States. The approval for animal experimentation was received from the Institutional Animal Ethics Committee of the Institute of Nuclear Medicine and Allied Sciences, Delhi, India. Inbred, 8-to 10-week-old male Swiss albino Strain A mice (weighing 25 to 30 g) were selected and maintained under controlled temperature (25°C ± 2°C), humidity (50% ± 5%), and light (14-hour and 10-hour light and dark, respectively) conditions. The animals had free access to sterile water and food.
Chemicals
Ethylene diamine tetra acetic acid, glacial acetic acid, hydrochloric acid, phosphoric acid, fetal calf serum, phosphate buffer saline, sodium dodecyl sulphate, polyacrylamide gel, nitrocellulose membrane, hemeoxygenase-1 (HO-1) and Bcl-2 antibody, mercaptoethanol, glycerol, tris-buffer saline, Tween-20, 5-bromo 3-chloro 4-indolyl phosphate nitroblue tetrazolium (BCIP-NBT), trypan blue, Leishman's stain, Coomassie brilliant blue, and bromophenol blue. All the chemicals were purchased from reputable firms (Sigma-Aldrich India, Bangalore, India; Merck, Darmstadt, Germany; Hi-media Laboratories Pvt. Ltd, Mumbai, India) for all the histological as well as molecular work. 
Determination of the Effect of P. hexandrum on Survival
Animals were administered desired doses of REC-2000 (50-250 mg/kg b.wt.) intraperitoneally 2 hours prior to whole-body 10 Gy gamma-irradiation. The survival study was performed for a period of 30-days postirradiation. Data were evaluated as the increase in log (% survival per unit Gy) with respect to increase in log (dose administered). Median survival time (MST) and percent increase in the life span were calculated using the following formulas: 
Determination of the Effect of P. hexandrum on Protein Expression
The animals were divided into the following 5 groups, and each group consisted of 3 animals: Group 1-The control animals were treated with 200 µL of phosphate buffer saline individually; Group 2-Animals were exposed to heat shock (42°C, for 30 minutes); Group 3-Animals were exposed to whole-body irradiation All experiments were carried out in triplicate. The animals were sacrificed by cervical dislocation 2 hours after the final treatment.
Irradiation Protocol
Two hours after injection of either normal saline or REC-2000, animals were placed in perforated plastic bottles. The animals were then exposed to 10 Gy at a dose rate of 0.54 rad/sec (GC-220, Atomic Energy Commission, Canada). Fresh air was continuously circulated in the irradiation chamber to avoid generation of hypoxic conditions. The animals were sacrificed on the 2nd, 7th, 10th, and 15th postirradiation days. Blood samples were drawn from the heart to estimate hemoglobin (Hb), total leukocyte count (TLC), and differential leukocyte count (DLC). Six animals were used in each experimental group.
Hemoglobin Estimation
Hemoglobin was estimated by the standard Sahli method. In short, 0.1 N HCl was taken in a graduated hemoglobinometer tube to which 20 µL of mouse blood was added. The mixture was kept for 10 minutes to convert hemoglobin to acid hematin, a brown-colored compound. After 10 to 15 minutes, distilled water was added dropwise with constant stirring until the color of the sample was matched with the standard. The value was expressed as hemoglobin content (g%).
Total Leukocyte Count
Total leukocyte counting was done using a Neubaur chamber. The blood sample (20 µL) was mixed with 480 µL of Turk's fluid (4% Glacial acetic acid) to bring about the lysis of all blood cells except leukocytes. After 10 to 15 minutes, the chamber was loaded with the sample and left for another 10 minutes to allow cells to settle down, followed by counting under the microscope (Olympus, Center Valley, PA). The cell count was expressed in terms of number of white blood cells/mm 3 .
Differential Leukocyte Count
A uniform blood smear was prepared on a glass slide. After drying, it was stained with Leishman's stain and left for 2 to 3 minutes (fixation time). Thereafter, the stain was diluted with buffered water (pH 6.8). After 10 minutes, the slides were washed thoroughly with water and dried. The slides were observed under light microscope in oil immersion, for DLC. Degree of recovery of all the 3 cells, namely, neutrophils, lymphocytes, and monocytes, in terms of percentage from the 7th day onward was calculated using the formula where Uc = number of cells in untreated control group; Rc = number of cells in radiation control group; (D+R) = number of cells in drug + radiation group; D = number of cells in the drug-only group. The degree of recovery was taken as zero when no cells were observed in the drug + radiation group.
Preparation of Tissue Homogenate
After appropriate treatments, animals were sacrificed and bone marrow was processed as per the method of Schmid, 11 and subsequently modified by Chaubey et al. 12 Briefly, the femur bone was removed and cleared of the adhering tissue. The marrow was flushed using a 26 G needle in a centrifuge tube containing fetal calf serum and centrifuged at 1000 rpm. The supernatant was removed with the help of a micropipette, and the cell pellet was suspended in lysis buffer and at room temperature for 24 hours. The cell mixture was further subjected to sonication to make a homogeneous cellfree suspension. The treatment and processing was carried out in 2 batches with equal number of animals.
Extraction of Total Soluble Cytoplasmic Proteins
Of the tissue homogenate, 1.5 mL was centrifuged at 12000 × g (30 min at 4°C) in a Sorvall super T21 refrigerated tabletop refrigerated centrifuge (Kendro Systems, Ramsey, MN). The supernatant was separated and recentrifuged at 15000 × g (30 min at 4°C). The clear supernatant was stored at -80°C for analysis of cytoplasmic fractions.
Protein Estimation
Total soluble protein content of bone marrow cellfree suspension was estimated. 13 The amount of protein was quantified using a bovine serum albumin standard curve for loading equal amount of protein in SDS-PAGE.
Sodium Dodecyl Sulphate-Polyacrylamide Gel Electrophoresis
SDS-PAGE was carried out on 10% polyacrylamide gels (0.75 mm thick). 14 The protein fractions were added to SDS-PAGE sample buffer (0.0625 M Tris-HCl, pH 6.8; 2% w/v SDS; 5% v/v glycerol; 2% v/v β-mercaptoethanol; 0.01% w/v bromophenol blue) and heated in a boiling water bath (SEW Instruments, Delhi, India) for 2 to 3 minutes. A fixed amount of protein (100 µg) was loaded in each well, and electrophoresis was carried out at constant voltage (stacking at 60 V, resolving at 70 V). Thereafter, the acrylamide gels were stained overnight with gentle shaking in 0.1% Coomassie brilliant R-250 in methanol : glacial acetic acid : water (4:2:4 v/v/v) at room temperature 14 and destained in a washing solution containing methanol : acetic acid : water (1:0.7:8.3). The gels were stored in 1% acetic acid to obtain the distinct bands over clear background.
Western Blotting
The proteins were transferred electrophoretically (100 V, 1 hour) onto a nitrocellulose membrane using a Bio-Rad Mini-Protean 3 cell transfer assembly (Bio-Rad, Hercules, CA). The membrane was blocked in a solution containing 5% w/v low-fat milk in TBS for 2 hours at room temperature. Levels of HO-1 and Bcl-2 were analyzed by probing with respective mouse monoclonal antibodies (1:1000 dilution). The membranes were washed thrice for 15 minutes each in washing buffer (Tris buffer saline, 0.2% Tween 20) and incubated in TBS containing 1:10000 dilution of goat antimouse IgG alkaline phosphates conjugated secondary antibodies. 15 The membranes were washed again with washing buffer 3 times each for 15 minutes and treated with BCIP-NBT (5-bromo-4-chloro-3-indolyl phosphate) reagent (Sigma) for 10 to 30 minutes. Densitometric analysis was carried out on a Bio-Rad gel documentation system utilizing Lab-Works Densitometric Analysis Software (Bio-Rad), containing automatic built-in BSA standards.
Statistical Analysis
The data were presented as mean ± standard deviation of the separate experiments. Significance was tested using t test and P < .05/P < .01 was considered significant.
Results
Effect of P. hexandrum on Survival
Different doses of REC-2000, ranging from 50 to 250 mg/kg b.wt., were administered 2 hours prior to 10 Gy exposure (Figure 1) . In a 30-day whole-body survival study, a dose-dependent increase in log (% survival per unit Gy) up to 200 mg/kg b.wt. was found to be 0.94. A 60% increase in median life span was observed in the drug (200 mg/kg b.wt.) + radiation group; therefore, this dose was chosen for further experimentation and evaluation of hemopoietic recovery.
Effect of P. hexandrum on Hemoglobin
The Hb content was determined in terms of g% of the hemoglobin present in unit volume of blood ( Figure 2) . No difference in Hb content was observed in the control group through the 15th day, and in the REC-2000-treated (200 mg/kg b.wt., -2 hours; i.p.) group on the 2nd day. On the 7th day, the Hb content was 13.95 ± 0.04 and no significant (P < .05) difference was observed on the 10th (13.85 ± 0.32) and 15th (13.9 ± 0.38) days as compared to control. In the radiation-only group (10 Gy), there was a transient increase in the Hb content (14.6 ± 0.18) on the 2nd day, which started decreasing subsequently until the 10th day (11.6 g%), after which no animal survived. 16 There was a marked decrease in the Hb content in the drug + radiation group from the 2nd day (14.9 ± 0.21) to the 7th day (12.1 ± 0.16). However, the Hb content started recovering soon thereafter and on the 10th day exhibited significant enhancement (21.25%) in Hb content as compared to the radiation-only group and returned to near control values by 15th day (14.73 ± 0.33).
Effect of P. hexandrum on Total Leukocyte Count
The total leukocyte count was expressed as number of leukocytes/mm 3 of blood. The control values remained unchanged from days 2 to 15. In the case of the drug-only group (Figure 3 ), there was a mild decrease in TLC on the 2nd day (2600 ± 15.93), which started recovering from the 7th day onward (2950 ± 84.77), and the values on the 10th and 15th days were found to be 3012.5 ± 171.73 and 3080 ± 353.95, respectively. In the radiation-only group, there was an abrupt decrease in the TLC. By the 2nd day, the TLC was 591.66 ± 136.15, which reduced to zero by the 10th day (when all the animals were dead). In the drug + radiation group, a similar pattern was observed through the 7th day. TLC was found to be 341.66 ± 18.22 on 2nd day and 110 ± 26.1 on 7th day. The TLC significantly increased (83.33 times) in the drug + radiation group as compared to radiation (10 Gy) only group on the 10th day. Thereafter, the animals started recovering from radiationinduced bone-marrow aplasia as evidenced by values of TLC (2916.7 ± 18.03 and 4166.66 ± 320.02 on the 10th and 15th days, respectively). The TLC attained near control value by the 15th posttreatment day.
Effect of P. hexandrum on Differential Leukocyte Count
Effect of P. hexandrum on Neutrophils
In untreated controls, the neutrophil count was 1427.7 ± 0.159, whereas in the drug-only group, neutrophil counts were 1058 ± 0.062, 1038 ± .008, 1082.37 ± 0.072, and 1009.6 ± 0.156 on the 2nd, 7th, 10th, and 15th days, respectively (Figure 4a ). The above difference in neutrophils was not significant between the 2 groups. In the radiation-only group, neutrophil count was 503 ± 0.156 on 2nd day, whereas the neutrophils were totally absent from the peripheral blood on the 7th and 10th days. However, the neutrophil count was found to be significantly (P < .05) higher, 1295 ± 0.109 and 1386.83 ± 0.12 on the 10th and 15th days, respectively, in the drug + radiation group as compared to the radiation-only group. 
Effect of P. hexandrum on Lymphocytes
In untreated controls, the lymphocyte count was 2009.5 ± 0.182, whereas in the drug-only group, lymphocytes were 1177 ± 0.044, 1489.37 ± 0.055, 1584 ± 0.109, and 1696.4 ± 0.163 on the 2nd, 7th, 10th, and 15th days, respectively (Figure 4b ). The above difference in levels of lymphocytes was not significant between the 2 groups. However, in the radiation-only group, lymphocyte count was 52 ± 0.012 on the 2nd day, whereas they were totally absent from the peripheral blood on the 7th and 10th days. The lymphocyte count was found to be 112 ± 0.014, 1383.3 ± 0.156, and 2231.83 ± 0.154 on the 2nd, 10th, and 15th days, respectively, in the drug + radiation group.
Effect of P. hexandrum on Monocytes
In untreated controls, the monocyte count was 542.8 ± 0.561 (Figure 4c) , whereas in the drug-only group, monocytes were 364.08 ± 0.322, 422.62 ± 0.368, 346.12 ± 0.291, and 374 ± 0.43 on the 2nd, 7th, 10th, and 15th days, respectively. This difference in monocyte count was not significant between the 2 groups. In the radiation-only group, monocyte count was 36.5 ± 0.102 on the 2nd day, which decreased substantially from the peripheral blood on the 7th day, and by the 10th day, all the animals died. However, monocyte count was found to be 44.75 ± 0.031, 155 ± 0.224, and 498 ± 0.576 on the 2nd, 10th, and 15th days, respectively; in the drug + radiation group, monocytes were found to be absent on the 7th day.
The degree of recovery (in terms of percentage) of all the 3 types of cells, namely, neutrophils, lymphocytes, and monocytes, from the 7th day onward in the drug + radiation group was calculated ( Figure  5 ). All the cells exhibited recovery from the 7th day onward; however, maximal recovery in the case of neutrophils (84.94%) and lymphocytes (89.99%) was observed on the 10th day, whereas in the case of monocytes, maximal recovery (77.15) was observed on the 15th day.
Effect of P. hexandrum on Heme-Oxygenase-I
The activity of HO-1 was evaluated densitometrically ( Figure 6 ). The present finding indicates that the expression of heme-oxygenase-1 in control and irradiated mice was nearly similar. A significant increase (P < .05) in expression of HO-1 in the heat shock group was observed, as compared to untreated control. HO-1 expression was found to increase significantly by 2.11-and 2.03-fold in the case of drug-only and drug + radiation groups, respectively. This study indicated up-regulation of HO-1 upon REC-2000 treatment.
Effect of P. hexandrum on Bcl-2 Expression
Bcl-2 expression was determined using Western blot analysis, followed by densitometric evaluation. As shown in Figure 7 , Western blot analysis revealed that intraperitoneal administration of REC-2000 to mice up-regulated the expression of Bcl-2 in bone marrow of mice by 2.28-to 2.3-fold, as compared to respective controls. However, no significant increase in the BCl-2 was observed in irradiated mice, or in the control group. Increased expression of Bcl-2 in the REC-2000-treated group as compared to irradiated mice indicated antiapoptotic potential of P. hexandrum.
Discussion
High-dose gamma radiation-induced depletion of the hematopoietic tissues coupled with compromised immunity are the main contributing factors to the hematopoietic syndrome and death in mammals. 17 Mice treated with REC-2000 maintained an average Hb (g%) of 13.85 ± 0.29 (as monitored from the 2nd to 15th days), which was nearly equivalent to the normal value. An initial rise in the Hb content in the radiation control group could be the result of a homeostatic response of the body against radiation exposure. The continuous decrease is an indication of the loss of progenitor cells to form new red blood cells. The decrease in Hb content can be related to either direct destruction of the RBCs or loss of RBCs in circulation hemorrhage or leakage through capillary walls, and loss of production of cells due to the direct effects of radiation on the dividing cells of the Figure 5 Effect of REC-2000 on the differential leukocyte count, evaluated by determining the degree of recovery of neutrophils, lymphocytes, and monocytes (in terms of percentage), from the 7th day onward. HO-1 = heme-oxygenase-1.
hemopoietic system. The drug + radiation group showed significant recovery only beyond the 10th day, thereby indicating that the bioactive constituents present in P. hexandrum were possibly acting as inducers of progenitor cell proliferation and also that the free-radical scavenging ability of P. hexandrum was playing a role in reducing the radiation effect. Total leukocyte count in the control group remained unchanged. However, in the drug-only group, there was a significant decrease in the leukocyte count on all experimental days, which could be due to the effect of the drug on the bone marrow, which might have affected the division of stem cells of myeloid and lymphoid series. This effect was slowly overcome until the 15th day. In the radiation-only group, the decrease in the TLC could be attributed to the destruction of (highly radiosensitive) lymphocytes, loss of cells due to hemorrhage or leakage of vascular tissue, and loss of production of white blood cell-forming stem cells. 17 Considering the leukocyte count of untreated control as 100% (3980 ± 228.91), REC-2000 administration exhibited maintenance of TLC ranging from 65.3% to 77.3% of normal values between the 2nd and 15th days. A pattern similar to the radiation-only group was observed in the drug + radiation group through the 7th day. After the 7th day, recovery in the leukocyte count was observed, which can be attributed to the free radical scavenging property and DNA protective ability of aryltetralin lignans and flavonoids, due to which cells were able to repair the damage induced by radiation at bone marrow level. Similarly, protection of the hemopoietic system has been reported by using tocopherol monoglucoside 18 and phytoextracts such as Adhatoda vasica, Hippophae rhamnoides, Aegle marmelos, and Syzygium cumini. 19, 20 The pattern of DLC in terms of neutrophils remained unchanged for the control group. A slight decrease in the neutrophil count was observed in the drug-only group from the 2nd day until the 15th day, which could be due to the toxicity associated with some of the constituents of the drug. There was a drastic decrease in the neutrophil count in the radiationonly group on the 2nd day, which dropped to zero by the 7th day because radiation sets up an emergent response that causes a sudden drop in the neutrophil count in the blood. The drug + radiation group, however, showed a nearly similar pattern to the radiationonly group through the 7th day but thereafter there was a significant (P < .05) recovery by the 10th and 15th days as compared to the radiation-only group. The bioactive constituents of the drug were possibly being metabolized and sequestered in the blood and initiating a cascade of pathways at a molecular/ cellular level to augment neutrophil recovery.
The lymphocyte count remained unchanged for the control group. A nonsignificant decrease in the lymphocyte count was observed on the 2nd day, which later increased by the 15th day in the drug-only group. A sharp decrease in the count was observed in the radiation-only group on the 2nd day, which dropped to zero by the 7th day (after which no animal survived in the group) as the immune system had failed completely. Administration of REC-2000 before irradiation (10 Gy) brought about a reversal in the pattern lymphocyte count after the 7th day. A significant recovery by the 10th and 15th days was observed, thereby indicating the immunostimulatory activity of the drug. These observations differ from those of previous workers, who have reported no significant effect on the differential count, 21 utilizing Thuja occidentalis. This difference is attributable to species-specific differences in terms of response.
The monocyte count in the control group remained unchanged. An apparent decrease (nonsignificant) in the monocyte count was observed from the 2nd day, which later improved by the 15th day. As nearly all the cells are ultimately affected by radiation because they originate from the stem cells of the bone marrow, there was a drastic decrease in the count in the radiation-only group by the 2nd day, which dropped to zero by the 7th day. The drug + radiation group also showed a significant (P < .05) decrease in monocyte count through the 7th day, but significant (P < .05) recovery was observed by the 10th and 15th days.
In earlier studies by our group, the herb Hippophae rhamnoides has been reported to augment radiorecovery of monocytes. 22 The degree of recovery (%) for neutrophils, lymphocytes, and monocytes in the drug + radiation group was calculated. Through the 7th day, the drug + radiation group showed a value of zero for all the cells. By the 10th day, the hemopoietic system showed recovery and a steep increase in percent recovery was observed for neutrophils (84.94%), lymphocytes (89.99%), and monocytes (64.78%) on the 10th day. This later on decreased slightly for neutrophils (73.57%) and lymphocytes (73.35%), but percent recovery for monocytes (77.15%) kept increasing until the 15th day. The steep increase in the value of % recovery is also indicative of the fact that the hemopoietic system is recovering from the radiationinduced stress at a fast pace between the 7th and 10th days, finally reaching a stable value by the 15th day.
To evaluate further evidence supporting the hemopoietic recovery, in the protein expression study, a significant up-regulation (P < .05) of HO-1 after REC-2000 treatment (with or without radiation) was observed. Overexpression of stress proteins has already been reported in response to heat shock as well as other environmental stresses, including ionizing radiation. 22, 23 HO-1 plays an essential role in the degradation of Hb-derived heme and is also a stress protein, commonly known as heat shock protein (HSP-32). The cytoprotective role of HO-1 against oxidative stress is well established. 24, 25 In the present study, the levels of HO-1 were up-regulated upon treatment with REC-2000. The expression of HO increases after exposure to heme derived from senescent/damaged erythrocytes or from heme proteins and under stressful conditions such as nutrient depletion, hypoxia, exposure to radiation, oxidants such as hydrogen peroxide, nitric oxide, heavy metals, or organic chemicals. 26, 27 It is apparent that the phytoconstituents present in REC-2000 increased HO levels. P. hexandrum elevated the level of HO-1, which in itself is indicative of cytoprotective effect. The radiation-only (10 Gy) group did not manifest much change as compared to control (nonsignificant) because HO-1 levels were measured within 2 hours after lethal irradiation. During this time period, the cells are in G 2 /M arrested phase. Because 10 Gy is a lethal dose for bone marrow (as reported earlier in Gupta et al., 2003) , all the protein synthesis is stopped. Therefore, at 2 hours the data represent only a constitutive level of protein (HO-1) due to which no difference in HO-1 levels was observed between the control and 10 Gy-irradiated groups. The diversity of stimuli that can induce HO-1 suggests that the molecular mechanisms that regulate HO-1 are quite complex. Several phytochemicals, including curcumin and carnosol, have been reported to induce HO-1 by regulating the expression and location of the Nrf2 transcription factor. 28, 29 However, the exact molecular mechanism by which REC-2000 up-regulates the expression of HO-1 needs to be investigated further.
Programmed cell death (apoptosis) is modulated by antiapoptotic and proapoptotic effectors, which involve a number of proteins. With a view to gaining an insight into the mechanisms involved in induction of apoptosis, and to explain the enhanced value of cell proliferation observed in mice treated with drug, we investigated the effect of REC-2000 on the antiapoptotic protein Bcl-2, an oncoprotein, which is known to play an important role in regulation of apoptosis. 30 The increased expression of Bcl-2 further strengthens our hypothesis that the active constituents of P. hexandrum, with reported antioxidant ability in the aqueous as well as lipid phase, [31] [32] [33] [34] induce gene expression of Bcl-2 to prevent a large-scale progenitor cell death mediated by the radiation-induced apoptotic pathway. The difference in expression of Bcl-2 in the case of the 10 Gy group as compared to control was nonsignificant because the levels were determined at 2 hours postirradiation and at this time point reflect only the constitutive levels. On the basis of the results obtained in the present study, we hypothesize that increased expression of Bcl-2 after REC-2000 administration is indicative of increased cell proliferation and survival of the hemopoietic cells. Further studies on hemopoietic stem cells are necessary to devise innovative drugs to tackle the radiation-induced hemopoietic syndrome resulting due to lethal radiation exposures.
In conclusion, the ability of REC-2000 to bring about a postirradiation hemopoietic recovery at therapeutic dose as well as the inherent antioxidant abilities of P. hexandrum make it a useful herbal drug for achieving radioprotection. The potential of this herbal drug could be even further used in numerous hematological disorders because it has been shown to be an inducer of HO-1. From the promising results obtained in the present study, it can be anticipated that herbal preparations from P. hexandrum could be widely exploited for protection of cancer patients in the clinic and other individuals accidentally exposed to radiation in scenarios such as dirty bombs and radiation accidents.
